Naturally dissolving stent shows promising trial results

A stent that dissolves leaving behind a restored vessel free of a permanent implant, with the potential to flex, pulse and dilate in response to various demands on the heart, has received a positive response following a trial in Japan. The one-year clinical results from ABSORB Japan, a multi-center, randomized trial, were presented at ESC Congress and published simultaneously in the European Heart Journal. The study considered the safety and effectiveness of Abbott’s fully dissolving Absorb heart stent when compared to XIENCE, Abbott’s permanent drug eluting stent. The trial was conducted in 38 sites in Japan and involved 400 people